XTL BIOPHARMACEUTICALS LTD. Adjustments For Decrease Increase In Trade Account Receivable
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Adjustments For Decrease Increase In Trade Account Receivable of $39.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Notes › Receivables
ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable · last filed 2025-04-30
| Period end | Adjustments For Decrease Increase In Trade Account Receivable 12 month |
|---|---|
| 2024-12-31 | $39.00K 20-F · filed 2025-04-30 |